chrX-54446174-G-A
Variant summary
Our verdict is Benign. Variant got -19 ACMG points: 1P and 20B. PP2BP4_StrongBP6_Very_StrongBS1BS2
The NM_004463.3(FGD1):c.2821C>T(p.Pro941Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000794 in 1,209,581 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 30 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. P941P) has been classified as Likely benign.
Frequency
Consequence
NM_004463.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -19 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
FGD1 | NM_004463.3 | c.2821C>T | p.Pro941Ser | missense_variant | 18/18 | ENST00000375135.4 | |
TSR2 | NM_058163.3 | c.*1624G>A | 3_prime_UTR_variant | 5/5 | ENST00000375151.5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
FGD1 | ENST00000375135.4 | c.2821C>T | p.Pro941Ser | missense_variant | 18/18 | 1 | NM_004463.3 | P1 | |
TSR2 | ENST00000375151.5 | c.*1624G>A | 3_prime_UTR_variant | 5/5 | 1 | NM_058163.3 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000107 AC: 12AN: 112172Hom.: 0 Cov.: 23 AF XY: 0.000146 AC XY: 5AN XY: 34348
GnomAD3 exomes AF: 0.000144 AC: 26AN: 180203Hom.: 0 AF XY: 0.000107 AC XY: 7AN XY: 65271
GnomAD4 exome AF: 0.0000765 AC: 84AN: 1097409Hom.: 0 Cov.: 31 AF XY: 0.0000689 AC XY: 25AN XY: 362833
GnomAD4 genome AF: 0.000107 AC: 12AN: 112172Hom.: 0 Cov.: 23 AF XY: 0.000146 AC XY: 5AN XY: 34348
ClinVar
Submissions by phenotype
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | May 18, 2018 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 24, 2023 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at